Metered Dose Inhaler Propellant Transition: US FDA Eager To Avoid Replay Of CFC-To-HFA ‘Complexity’

 
• By Michael McCaughan

The US FDA wants a smoother transition to newer “low global warming potential” propellants in metered dose inhalers than the prior transition away from CFCs.

The FDA wants the transition to "low global warming potential" metered dose inhaler propellants to have a minimal impact on patients. (Shutterstock)

More from Generics

More from Pathways & Standards